Bio-Rad Laboratories (BIO) Long-Term Deferred Tax (2009 - 2019)

Bio-Rad Laboratories (BIO) has 11 years of Long-Term Deferred Tax data on file, last reported at $138.0 million in Q4 2019.

• Long-Term Deferred Tax for Q4 2019 came in at $138.0 million, up 80.87% year-over-year; the trailing twelve-month figure through Dec 2019 was $138.0 million (up 80.87% YoY), and the FY2019 annual result was $138.0 million, up 80.87% from the prior year.
• Long-Term Deferred Tax grew to $138.0 million in Q4 2019 per BIO's latest filing, from $76.3 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $138.0 million in Q4 2019 and troughed at $76.3 million in Q4 2018.
• A 5-year average of $102.2 million and a median of $99.5 million in 2015 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2017 and 2019: Long-Term Deferred Tax plunged 32.77% in 2017, then surged 80.87% in 2019.
• A 5-year view of Long-Term Deferred Tax shows it stood at $99.5 million in 2015, then grew by 18.39% to $117.8 million in 2016, then sank by 32.77% to $79.2 million in 2017, then decreased by 3.66% to $76.3 million in 2018, then soared by 80.87% to $138.0 million in 2019.
• Business Quant data shows BIO's Long-Term Deferred Tax at $138.0 million in Q4 2019, $76.3 million in Q4 2018, and $79.2 million in Q4 2017.